Academic
Publications
The Rate of Viral Rebound after Attainment of an HIV Load <50 Copies/mL According to Specific Antiretroviral Drugs in Use: Results from a Multicenter Cohort Study

The Rate of Viral Rebound after Attainment of an HIV Load <50 Copies/mL According to Specific Antiretroviral Drugs in Use: Results from a Multicenter

The Rate of Viral Rebound after Attainment of an HIV Load <50 Copies/mL According to Specific Antiretroviral Drugs in Use: Results from a Multicenter Cohort Study   (Citations: 11)
BibTex | RIS | RefWorks Download
Journal: Journal of Infectious Diseases - J INFEC DIS , vol. 192, no. 8, pp. 1387-1397, 2005
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...In addition, 2 analyses of observational studies were performed recently, the first showing a difference in the rate of viral rebound that favored efavirenz over abacavir, both in antiretroviral-naive patients and in antiretroviral-experienced patients [30], and the second showing little difference, possibly because of the small number of events/person-years available for analysis [31]...
    • ...Our estimate of the rate of viral rebound (4.8% per year) was very similar to those estimated in other observational studies (6.3 per 100 PYFU in the UK Collaborative HIV Cohort [CHIC] analysis [30] and 4.9 per 100 PYFU in the EuroSIDA analysis [31])...
    • ...This result is consistent with those obtained in a nonrandomized comparison performed within the ACTG 5095 trial and in the CHIC analysis [21, 30]...
    • ...In general, our data showing the inferiority of stavudine/didanosine to zidovudine/ lamivudine are in agreement with the results of other recent nonrandomized comparisons [30, 31]...

    Marco Bongiovanniet al. A Comparison between Abacavir and Efavirenz as the Third Drug Used in ...

Sort by: